Serum levels of CA 125 and histological findings at second-look laparotomy in ovarian carcinoma
- 1 October 1989
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 35 (1) , 44-46
- https://doi.org/10.1016/0090-8258(89)90008-5
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- CA-125 in gynecological malignanciesEuropean Journal of Cancer and Clinical Oncology, 1987
- CA 125 in gynecologic practiceAmerican Journal of Obstetrics and Gynecology, 1986
- CA 12–5 serum levels and histological findings at second look in patients with ovarian cancerZeitschrift für Krebsforschung und Klinische Onkologie, 1986
- Longitudinal study of CEA and CA125 in ovarian cancerGynecologic Oncology, 1985
- Predictive value of CA 125 antigen levels in second-look procedures for ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1985
- Erfahrungen mit CA 125, einem Tumormarker für maligne epitheliale Ovarialtumoren*Geburtshilfe und Frauenheilkunde, 1985
- Stage III epithelial ovarian cancer: The role of maximal surgical reductionGynecologic Oncology, 1984
- Second-look laparotomy in epithelial ovarian carcinoma: Precise definition, sensitivity, and specificity of the operative procedureGynecologic Oncology, 1984
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983
- Reactivity of a monoclonal antibody with human ovarian carcinoma.Journal of Clinical Investigation, 1981